FDA approve pneumococcal 20-valent conjugate vaccine (PREVNAR 20) for adults

This conjugate vaccine has been designed to protect against 20 serotypes. In addition to the 13 serotypes in PREVENAR 13, this product contains conjugates for serotypes 8, 10A, 11A, 12F, 15B, 22F and 33F. Formal review of marketing authorisation application by the EMA is ongoing

Source:

Biospace Inc.